HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.

AbstractBACKGROUND:
Since testing for antineutrophil cytoplasmic antibodies (ANCA) became available for routine evaluation, no large homogeneous cohort of patients with the Churg-Strauss syndrome has been studied.
OBJECTIVE:
To define the clinical and biological characteristics of newly diagnosed Churg-Strauss syndrome, according to the presence or absence of ANCA.
DESIGN:
Cross-sectional analysis of manifestations of participants who were enrolled in treatment trials between December 1995 and December 2002.
SETTING:
Multicenter study in 63 clinical centers in France, Belgium, Latvia, and the United Kingdom, coordinated by the French Vasculitis Study Group.
PARTICIPANTS:
112 patients with Churg-Strauss syndrome that was recently diagnosed on the basis of current classifications.
MEASUREMENTS:
The authors compared principal demographic, clinical, and laboratory features according to ANCA status at diagnosis.
RESULTS:
The authors detected ANCA in 43 (38%) patients. Positive ANCA status at diagnosis was associated with renal involvement, peripheral neuropathy, and biopsy-proven vasculitis, whereas negative ANCA status was associated with heart disease and fever.
LIMITATIONS:
The authors assessed ANCA by immunofluorescence, but they did not assess ANCA centrally or systematically retest if ANCA was undetected at diagnosis.
CONCLUSIONS:
Phenotypically, ANCA-positive and ANCA-negative Churg-Strauss syndrome might differ. The association of ANCA positivity with clinical symptoms that indicate inflammation and necrosis of small vessels might characterize a predominantly vasculitic pattern of the Churg-Strauss syndrome.
AuthorsRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, Christian Pagnoux, Luc Mouthon, David Jayne, Daniel Blockmans, Jean-François Cordier, Philippe Delaval, Xavier Puechal, Dominique Lauque, Jean-François Viallard, Abdelkader Zoulim, Loïc Guillevin, French Vasculitis Study Group
JournalAnnals of internal medicine (Ann Intern Med) Vol. 143 Issue 9 Pg. 632-8 (Nov 01 2005) ISSN: 1539-3704 [Electronic] United States
PMID16263885 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic (immunology)
  • Churg-Strauss Syndrome (blood, complications, diagnosis)
  • Cross-Sectional Studies
  • Female
  • Fever (etiology)
  • Heart Diseases (etiology)
  • Humans
  • Kidney Diseases (etiology)
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases (etiology)
  • Prognosis
  • Prospective Studies
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: